Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R24DK110499, R24DK110499)
Received: 19 August 2020
Accepted: 19 January 2021
First Online: 5 April 2021
: C.H. is a scientific advisor for Seres Therapeutics, Empress Therapeutics and ZOE Nutrition. W.S.G. is a scientific advisor for Senda Therapeutics, Leap Therapeutics, Evelo Biosciences, Tenza Inc. and SanaRx.